CME Group Inc. (NASDAQ:CME) insider Sunil Cutinho sold 2,600 shares of the stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $139.57, for a total transaction of $362,882.00. Following the sale, the insider now owns 22,301 shares in the company, valued at approximately $3,112,550.57. The transaction was disclosed in a document filed with the SEC, which is available at this link.
CME Group Inc. (NASDAQ CME) opened at $141.90 on Tuesday. The stock has a market cap of $47,650.00, a price-to-earnings ratio of 29.18, a PEG ratio of 2.86 and a beta of 0.71. CME Group Inc. has a 52 week low of $111.19 and a 52 week high of $142.64. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.05 and a current ratio of 1.05.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The firm had revenue of $890.80 million during the quarter, compared to the consensus estimate of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.05 earnings per share. sell-side analysts forecast that CME Group Inc. will post 4.78 EPS for the current fiscal year.
WARNING: “CME Group Inc. (CME) Insider Sunil Cutinho Sells 2,600 Shares of Stock” was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://sportsperspectives.com/2017/11/21/cme-group-inc-cme-insider-sunil-cutinho-sells-2600-shares-of-stock.html.
Several hedge funds have recently added to or reduced their stakes in the company. Honkamp Krueger Financial Services Inc. raised its stake in shares of CME Group by 0.4% during the second quarter. Honkamp Krueger Financial Services Inc. now owns 2,937 shares of the financial services provider’s stock valued at $368,000 after acquiring an additional 13 shares during the last quarter. Hudock Capital Group LLC raised its stake in CME Group by 0.5% during the second quarter. Hudock Capital Group LLC now owns 3,890 shares of the financial services provider’s stock worth $487,000 after buying an additional 20 shares during the last quarter. Whittier Trust Co. raised its stake in CME Group by 2.6% during the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after buying an additional 27 shares during the last quarter. Ropes Wealth Advisors LLC raised its stake in CME Group by 0.4% during the second quarter. Ropes Wealth Advisors LLC now owns 10,801 shares of the financial services provider’s stock worth $1,353,000 after buying an additional 38 shares during the last quarter. Finally, CAPROCK Group Inc. raised its stake in CME Group by 0.9% during the second quarter. CAPROCK Group Inc. now owns 5,787 shares of the financial services provider’s stock worth $725,000 after buying an additional 50 shares during the last quarter. 82.58% of the stock is owned by hedge funds and other institutional investors.
A number of analysts have weighed in on the stock. BidaskClub upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research report on Thursday, August 3rd. Keefe, Bruyette & Woods restated a “hold” rating and issued a $127.00 target price on shares of CME Group in a research report on Friday, August 18th. Royal Bank Of Canada set a $135.00 target price on shares of CME Group and gave the company a “buy” rating in a research report on Tuesday, August 1st. Barclays PLC raised their target price on shares of CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research report on Tuesday, October 10th. Finally, Wells Fargo & Company raised their target price on shares of CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research report on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and seven have given a buy rating to the company’s stock. CME Group presently has an average rating of “Buy” and a consensus target price of $141.75.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.